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caused by large-vessel occlusion, the high e-ASPECTS value 
supported the decision to initiate intra-arterial treatment 
and triage the patient to a comprehensive stroke center. In 
case 3, the e-ASPECTS value was 10, indicating the absence 
of early infarct signs despite pre-existing cerebral microan-
giopathy and macroangiopathy, a finding indicating the 
program’s robustness against artefacts.  Conclusions: This 
study on the integration of e-ASPECTS into the prehospital 
stroke management via a MSU showed for the first time that 
such integration is feasible, and aids both decision regarding 
the treatment option and the triage regarding the most ap-
propriate target hospital.  © 2016 S. Karger AG, Basel 
 Introduction 
 In the management of acute stroke, ‘time is brain’  [1] . 
A mobile stroke unit (MSU), incorporating all the tools 
necessary for guideline-adherent and etiology-specific 
treatment directly at the emergency site, was proposed in 
2003  [2] and shown to facilitate prehospital thrombolysis 
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 Abstract 
 Background: Recently, a mobile stroke unit (MSU) was 
shown to facilitate acute stroke treatment directly at the 
emergency site. The neuroradiological expertise of the MSU 
is improved by its ability to detect early ischemic damage via 
automatic electronic (e) evaluation of CT scans using a novel 
software program that calculates the electronic Alberta 
Stroke Program Early CT Score (e-ASPECTS).  Methods: The 
feasibility of integrating e-ASPECTS into an ambulance was 
examined, and the clinical integration and utility of the soft-
ware in 15 consecutive cases evaluated.  Results: Implemen-
tation of e-ASPECTS onto the MSU and into the prehospital 
stroke management was feasible. The values of e-ASPECTS 
matched with the results of conventional neuroradiologic 
analysis by the MSU team. The potential benefits of 
 e-ASPECTS were illustrated by three cases. In case 1, exclud-
ing early infarct signs supported the decision to directly per-
form prehospital thrombolysis. In case 2, in which stroke was 
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in 2009  [3] . The MSU is an ambulance that includes CT 
scan for multimodal imaging with a quality comparable to 
that of a stationary CT scanner  [4] ; a point-of-care labora-
tory system  [5] ; and a telemedicine connection to the hos-
pital  [2, 3] . A first randomized trial of the MSU found a 
50% reduction in delay from stroke onset to treatment  [6] .
 Currently, programs for prehospital stroke treatment 
are in operation at several stroke centers  [7–14] . Reports 
from these programs confirm the enormous time gain as-
sociated with prehospital stroke treatment and show that 
treatment rates can be significantly increased  [9] .
 More importantly, prior to providing successful re-
canalization therapy and reducing the risk of hemor-
rhage, the results of CT scans must exclude signs of estab-
lished ischemia. A post-hoc analysis of the European Co-
operative Acute Stroke Study found that the presence of 
early signs of infarction was an important predictor of 
poorer response to intravenous (IV) thrombolysis  [15] 
and a higher rate of adverse effects  [16] .
 The interpretation of CT scans performed during the 
first hours after suspected stroke is often difficult  [15] , 
because the interpretation of subtle signs such as loss of 
the grey-white matter interface or parenchymal hypoat-
tenuation requires substantial expertise  [17] and is sub-
ject to considerable interrater variability  [18, 19] . As a 
solution to this problem, the Alberta Stroke Program Ear-
ly CT Score (ASPECTS) was proposed. This is a standard-
ized topographic system for scoring CT scans performed 
in the setting of acute ischemic stroke. It divides the ter-
ritory of the middle cerebral artery (MCA) into 10 areas 
of interest within 2 specified levels  [20] .
 The ASPECTS value has been shown to be associated 
with vascular pathology  [21, 22] and is a simple and ac-
curate predictor of functional outcome after thrombolytic 
treatment  [20, 23, 24] . Patients with an ASPECTS value 
higher than 7 will probably respond to treatment, whereas 
those with a value lower than 5 are much less likely to ben-
efit  [25] . Thus, the use of ASPECTS value has been recom-
mended by the American Society of Neuroradiology  [26] . 
More recently, ASPECTS has also been used for selecting 
patients for enrolment into endovascular treatment trials 
that include only patients with a high  ASPECTS value 
 [27–29] . In a subgroup analysis of another endovascular 
treatment trial, the odds ratio favoring the intervention 
was higher in patients with lower ASPECTS value  [30] .
 However, the fact that detecting early ischemic chang-
es from non-contrast CT scan requires expertise from the 
clinician is an important reason for the limited applica-
tion  of ASPECTS. Therefore, the electronic ASPECTS 
 (e-ASPECTS) software was developed for providing a 
standardized, fully automated decision-support tool  [31] . 
The performance of the e-ASPECTS software has been 
shown to be equivalent in sensitivity and specificity to the 
manual interpretation of non-contrast CT scans by trained 
stroke physicians and neuroradiologists when diffusion-
weighted MRI is used as a ground truth reference  [32] .
 A recent editorial proposed that the integration of 
 ASPECTS into the MSU concept could potentially in-
crease neuroradiological competence during the prehos-
pital phase of stroke management  [33] . In this study, the 
feasibility of incorporating an automated stroke imaging 
software (e-ASPECTS, Brainomix Ltd., Oxford, UK) into 
the MSU concept was assessed for the first time and its 
clinical use for the treatment of acute stroke patients di-
rectly at the emergency site evaluated.
 Methods and Patients 
 Patients and Context of the Investigation 
 A total of 15 consecutive patients were evaluated for determin-
ing the feasibility and benefit of the e-ASPECTS software in stroke 
management in a MSU. Patients were studied in the context of a 
larger study of prehospital stroke treatment that was approved by 
the Ethical Committee of the Physicians’ Chamber of Saarland. All 
patients provided written informed consent for participation.
 MSU Strategy 
 The MSU is an ambulance equipped with all the standard tools 
for emergency care with the following special equipments: (i) an 
accumulator-driven and lead-shielded CT scanner (CereTom, 
NeuroLogica/Samsung, Danvers, Mass., USA), allowing multi-
modal imaging; (ii) a telemedicine system (MEYTEC, Wer-
neuchen, Germany), enabling the transmission of digital imaging 
and communication data obtained by CT scanning or video of 
clinical examination via the universal mobile telecommunication 
system to the picture archiving and communication system of the 
hospital; and (iii) a point-of-care laboratory system for measuring 
the platelet count, leukocyte count, erythrocyte count, hemoglobin 
level, and hematocrit (PocH 100i, Sysmex, Hamburg, Germany); 
international normalized ratio (INR) and activated partial throm-
boplastin time (Hemochron Jr., ITC, Edison, N.Y., USA); and  γ -
glutamyltransferase activity, p-amylase activity, and glucose con-
centration (Reflotron Plus, Roche Diagnostics Mannheim, 
 Germany)  [3, 6] .
 The emergency medical service (EMS) dispatch center dis-
patches the MSU in parallel with the regular EMS to assess patients 
with suspected acute stroke.
 Implementation of e-ASPECTS Software in a MSU 
 The e-ASPECTS software (Brainomix Ltd., Oxford, UK) auto-
mates the ASPECTS method. It is a fully automated, topographic, 
quantitative, and Conformité Européene (CE)-marked scoring 
tool for detecting early ischemic damage on CT scans. This rater-
independent software was developed for standardizing the inter-
pretation of CT scans and for making the interpretation readily 
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available. Following pre-processing of input images, a registration 
step corrects for any 3D rotation and misalignment (e.g. tilt). Im-
age features are then extracted and regions are scored with a ma-
chine learning classifier that identifies early ischemic signs.
 Non-contrast enhanced scans were obtained with the MSU’s 
Ceretom scanner and then evaluated using the e-ASPECTS soft-
ware. Two integration approaches were investigated, both using 
the native continuous spiral data acquisition protocol on the scan-
ner, resulting in a minimal slice thickness of 1.25 mm. The first 
integration approach is based on the use of a laptop computer with 
an Intel Core i7 processor as the e-ASPECTS server. To avoid 
changing the configuration of other MSU devices, a manual work-
flow was implemented in which scans were exported from the 
viewing workstation on the MSU, compressed, and uploaded 
through the e-ASPECTS web-based user interface (UI) by hand. 
Results were then viewed through the viewing workstation, again 
using the e-ASPECTS web-based UI. The second integration ap-
proach supported a streamlined workflow. Scans were pushed via 
the Digital Imaging and Communications in Medicine (DICOM) 
network protocol to the e-ASPECTS server over a standard local 
area network connection. The server automatically processed the 
images and pushed annotated result images back to the viewing 
workstation, again over the DICOM network protocol. It was also 
possible to generate e-mail notifications containing anonymized 
images, if necessary. This approach considerably simplified the 
user workflow, although it required reconfiguring the network 
and  devices in the MSU to allow DICOM communication to 
 e-ASPECTS.
 The standardized topographic scoring system, ASPECTS, di-
vides the territory of MCA into 10 areas of interest within 2 speci-
fied levels: the level of the basal ganglia and the level of the supra-
ganglionic structure  [20] . Analysis of each region of the brain for 
signs of ischemic damage generates the ASPECTS value. Addition-
al details of the software have been described elsewhere  [31, 32] .
 In this study, the e-ASPECTS values were also compared with 
the results obtained by neuroradiologists (A.R.-S., M.K., S.R.) on 
the MSU team, who manually analyzed the scans for early signs of 
infarction.
 Results 
 Obtaining e-ASPECTS Values of Patients with Acute 
Stroke Symptoms 
 Fifteen consecutive patients (2 men, 13 women) with 
symptoms of acute stroke were examined in the MSU 
with e-ASPECTS. The median age of the patients was 82 
years (interquartile range (IQR) 71–85 years). The pa-
tients’ median score on the National Institutes of Health 
Stroke Scale (NIHSS) was 4 (IQR 1–6); and that on the 
Los Angeles Motor Scale (LAMS) was 1 (IQR 0–4).
 For these patients, the median stroke management 
times were as follows: time from symptom onset to alarm, 
54 min (IQR 19–125 min); time from symptom onset to 
MSU arrival, 64 min (IQR 30–159 min); time from symp-
tom onset to CT scan, 93 min (IQR 62–181 min); and 
time from symptom onset to thrombolysis, 85 min (IQR 
58–154 min).
 Twelve patients scored an e-ASPECTS value of 10; 1 
scored a value of 9. Obtaining an e-ASPECTS value for 
the other 2 patients was not possible because of the poor 
quality of source CT images. These e-ASPECTS values 
matched with the results of conventional evaluation by 
neuroradiologists on the MSU team.
 Three exemplary clinical cases are presented below.
 Case 1. e-ASPECTS Value Suggesting Absence of Early 
Signs of Infarction Assisted in the Decision to Perform 
Prehospital IV Thrombolysis 
 A 71-year-old woman collapsed. Neurological exami-
nation by the MSU team found right-sided facial paresis 
and hemiparesis (grade 0/5) and mild dysarthria (NIHSS 
score 16; modified Rankin Scale (mRS) score 5; LAMS 
score 5). Results of point-of-care laboratory tests (INR, 
activated partial thromboplastin time, glucose level, leu-
kocyte count, platelet count, erythrocyte count, p-amy-
lase activity, and  γ -glutamyltransferase activity) were 
normal.
 The prehospital scans showed no intracranial bleed-
ing, no demarcation of cerebral contusion, and no new 
infarction ( fig. 1 a). CT angiography showed no large-ves-
sel occlusion. The e-ASPECTS value was 10 ( fig. 1 b). The 
therapy decision was prehospital thrombolysis.
 The following time metrics of stroke management 
were obtained: time from symptom onset to alarm, 14 
min; time from symptom onset to MSU arrival, 23 min; 
time from symptom onset to CT scan, 57 min; and time 
from symptom onset to thrombolysis, 59 min.
 The patient responded well to thrombolytic treatment 
and was discharged after 1 week with no neurological def-
icit (NIHSS score 0; mRS score 0).
 Case 2. e-ASPECTS Value Suggesting Absence 
of Early Infarct Signs in an Acute Stroke Patient with 
Large-Vessel Occlusion Assisted in Decision for Bridging 
IV Thrombolysis and Triage to a Comprehensive Stroke 
Center for Intra-Arterial Treatment 
 Upon arrival, the MSU team found a 73-year-old 
woman on the floor. Neurological examination found a 
right-sided hemiparesis (grade 1/5), global aphasia, mild 
somnolence, and ocular deviation to the left side (NIHSS 
score 20; LAMS score 4). Results of point-of-care labora-
tory tests were normal.
 The CT scans showed no intracranial bleeding, no de-
marcation of cerebral contusion, and no infarction 
( fig. 1 c); however, a proximal (M1) occlusion of the left 
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 Fig. 1. Axial unenhanced CT images ac-
quired in the prehospital setting of the 
MSU (left panel), and e-ASPECTS seg-
mentation of these images (right panel). 
 a ,  b The e-ASPECTS software showed that 
no early infarct signs were present 
 (ASPECTS value, 10) and assisted in the 
decision for prehospital thrombolysis in a 
patient with acute stroke.  c ,  d For a patient 
with acute stroke caused by large-vessel 
occlusion, an e-ASPECTS value of 10 as-
sisted in the decision for prehospital bridg-
ing thrombolysis, followed by intra-arteri-
al treatment in a comprehensive stroke 
center.  e ,  f For an acute stroke patient with 
signs of pre-existing cerebral microangi-
opathy and older ischemic lesions in the 
left MCA territory, detection of early isch-
emic signs was difficult. However, an e-
ASPECTS value of 10 assisted in the inter-
pretation against early infarct signs and in 
making the decision to treat the patient 
with prehospital thrombolysis. 
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MCA was visible upon CT angiography. The e-ASPECTS 
value was 10 ( fig. 1 d). Because CT ruled out hemorrhage 
and e-ASPECTS confirmed the absence of early signs of 
infarction, the therapy decision was immediate bridging 
thrombolysis and triage to the closest comprehensive 
stroke center for subsequent intra-arterial treatment.
 The following time metrics of stroke management 
were determined: time from symptom onset to alarm, 56 
min; time from symptom onset to MSU arrival, 75 min; 
time from symptom onset to CT, 90 min; time from 
symptom onset to bridging thrombolysis, 95 min; time 
from symptom onset to arrival at the comprehensive 
stroke center, 133 min; and time from symptom onset to 
groin puncture, 165 min.
 Upon discharge to a rehabilitation facility after 10 days, 
the patient’s aphasia had improved slightly, although the 
hemiparesis persisted (NIHSS score 14; mRS score 5).
 Case 3. e-ASPECTS Indicating Absence of Early 
Infarct Signs Despite Pre-Existing Older Cerebral 
Microangiopathy and Macroangiopathy in CT 
 An 89-year-old woman reported acute onset of begin-
ning paresis of the left extremities. Neurological exami-
nation found paresis of the left arm (grade 4/5) and left 
leg (grade 0/5), but no sensory deficits (NIHSS score 5; 
LAMS score 2). The results of all point-of-care laboratory 
tests were normal.
 Prehospital CT images showed no intracranial bleed-
ing and no demarcation of cerebral contusion; however, 
they showed pre-existing pronounced cerebral microan-
giopathy and signs of older ischemic lesions in the left 
MCA territory ( fig.  1 e). The e-ASPECTS value was 10 
( fig. 1 f), a value suggestive of the absence of early signs of 
infarction. The therapy decision was immediate prehos-
pital thrombolysis.
 The time metrics of stroke management were: time 
from symptom onset to alarm, 28 min; time from symptom 
onset to MSU arrival, 37 min; time from symptom onset to 
CT scan, 66 min; and time from symptom onset to throm-
bolysis, 100 min. After 1 week, the patient’s  neurological 
status improved with a grade 4/5 paresis left arm and grade 
3/5 paresis left leg (NIHSS score 3; mRS score 3).
 Discussion 
 Correct identification of early signs of demarcating ce-
rebral infarction is important in selecting patients for re-
canalization treatment. Because the administration of 
prehospital thrombolysis is increasingly being studied at 
many stroke centers in several countries  [3, 6–14] , the 
availability of a tool that could evaluate CT images and 
detect signs of infarction in an ambulance in a standard-
ized manner would be of considerable medical interest. 
This study demonstrates the feasibility and potential clin-
ical benefit of integrating the e-ASPECTS software for the 
automated detection of early ischemic damage in a MSU.
 Obtaining an ASPECTS value in the prehospital stage 
of stroke management was possible for 13 of the 15 pa-
tients. In 2 cases, images were severely impaired by head-
movement artefact,  precluding both manual and auto-
mated ASPECTS scoring. Movement artefacts are some-
times a problem in agitated patients, and it was found that 
the software correctly alerted to their presence. Most of 
the patients included in this study had an e-ASPECTS 
value of 10. The scores matched with the results of man-
ual interpretation of early signs of infarction on the CT 
images by the neuroradiologists on board the MSU.
 All patients in this series had high e-ASPECTS values, 
a finding that can be explained by the fact that for all 15 
patients the time between stroke onset and CT imaging 
was short. The median time from symptom onset to CT 
imaging for the study patients was 93 min (IQR 62–181 
min). This work was part of the prehospital stroke treat-
ment program in which the MSU was dispatched mainly 
to hyperacute stroke patients. Moreover, the response 
times of the MSU and the times to diagnostic work-up are 
faster than those in the conventional hospital approach 
 [6–14] . Indeed, the finding of very high e-ASPECTS val-
ues matched with the findings of median scores of 9 in a 
recent thrombectomy study, in which response times 
were also very short (median symptom onset-to-needle 
times of 85 min)  [30] .
 The exemplary cases illustrate the potential of this au-
tomated, rater-independent imaging software in assisting 
the MSU team in both therapy decisions and triage deci-
sions directly at the emergency site. Case 1 illustrates the 
potential medical benefit of excluding early signs of in-
farction with e-ASPECTS software, thereby assisting the 
MSU team in making a decision for immediate prehospi-
tal thrombolysis of acute ischemic stroke.
 According to recent evidence, endovascular stroke 
therapy for the anterior circulation is likely to become the 
‘new standard of care’ for patients with large-vessel occlu-
sion  [34] . Because appropriate patient selection for endo-
vascular treatment is crucial, the e-ASPECTS software 
could also be beneficial in this regard, thereby standard-
izing patient care  [27, 30, 31, 35] . In case 2, the software 
supported the decision to provide bridging IV thrombol-
ysis followed by endovascular treatment in a comprehen-
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sive stroke center for an acute stroke patient with large-
vessel occlusion and no early signs of infarction. Thus, 
apart from therapy decisions, e-ASPECTS software can 
assist in triage decisions with regard to the most appro-
priate target hospital, for example, comprehensive stroke 
unit vs. primary stroke unit.
 Finally, for one acute stroke patient, manual interpre-
tation of the CT images was difficult because of marked 
signs of pre-existing older cerebral microangiopathy and 
macroangiopathy. The e-ASPECTS value was 10, a find-
ing indicating the robustness of this scoring tool against 
potential sources of non-acute ischemic hypodensities. 
This patient was treated with thrombolysis directly at the 
emergency site with marked clinical benefit.
 It was not the aim of this study to evaluate accuracy of 
the e-ASPECTS software as the software is already CE 
marked as a decision support tool for the detection of 
early ischemic damage, and the performance has been 
validated as part of the CE marking process. In addition, 
Herweh et al.  [32] demonstrated in an independent study 
that the performance of e-ASPECTS is equivalent to ex-
pert neuroradiologists.
 In prehospital stroke treatment, neuroradiological 
competence may be provided in several ways, for exam-
ple, by the presence of specifically trained physicians in 
the ambulance  [3, 5] or by telemedicine support for the 
MSU team so that images can be evaluated by experts in 
the hospital. In the United States, the latter approach has 
recently been shown to be very reliable because of the 
widespread availability of 4G connectivity and the pri-
oritization of EMS telecommunications  [13] . In both 
configurations, the e-ASPECTS software could be a valu-
able second-opinion instrument that could assist the phy-
sician in making an assessment.
 Conclusion 
 This preliminary report shows for the first time that 
integrating e-ASPECTS software into a MSU is feasible 
and can provide information relevant to decisions re-
garding prehospital stroke treatment and selection of the 
most appropriate target hospital.
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